These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35416776)

  • 1. Real world outcomes and implementation pathways of exome sequencing in an adult genetic department.
    Walsh M; West K; Taylor JA; Thompson BA; Hopkins A; Sexton A; Ragunathan A; Verma KP; Panetta J; Matotek E; Fahey MC; Christie M; Winship IM; Trainer AH; James PA
    Genet Med; 2022 Jul; 24(7):1536-1544. PubMed ID: 35416776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic exome sequencing in 100 consecutive patients with both epilepsy and intellectual disability.
    Snoeijen-Schouwenaars FM; van Ool JS; Verhoeven JS; van Mierlo P; Braakman HMH; Smeets EE; Nicolai J; Schoots J; Teunissen MWA; Rouhl RPW; Tan IY; Yntema HG; Brunner HG; Pfundt R; Stegmann AP; Kamsteeg EJ; Schelhaas HJ; Willemsen MH
    Epilepsia; 2019 Jan; 60(1):155-164. PubMed ID: 30525188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability.
    Sabo A; Murdock D; Dugan S; Meng Q; Gingras MC; Hu J; Muzny D; Gibbs R
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1439. PubMed ID: 32767738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
    Srivastava S; Love-Nichols JA; Dies KA; Ledbetter DH; Martin CL; Chung WK; Firth HV; Frazier T; Hansen RL; Prock L; Brunner H; Hoang N; Scherer SW; Sahin M; Miller DT;
    Genet Med; 2019 Nov; 21(11):2413-2421. PubMed ID: 31182824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort.
    Dias KR; Shrestha R; Schofield D; Evans CA; O'Heir E; Zhu Y; Zhang F; Standen K; Weisburd B; Stenton SL; Sanchis-Juan A; Brand H; Talkowski ME; Ma A; Ghedia S; Wilson M; Sandaradura SA; Smith J; Kamien B; Turner A; Bakshi M; Adès LC; Mowat D; Regan M; McGillivray G; Savarirayan R; White SM; Tan TY; Stark Z; Brown NJ; Pérez-Jurado LA; Krzesinski E; Hunter MF; Akesson L; Fennell AP; Yeung A; Boughtwood T; Ewans LJ; Kerkhof J; Lucas C; Carey L; French H; Rapadas M; Stevanovski I; Deveson IW; Cliffe C; Elakis G; Kirk EP; Dudding-Byth T; Fletcher J; Walsh R; Corbett MA; Kroes T; Gecz J; Meldrum C; Cliffe S; Wall M; Lunke S; North K; Amor DJ; Field M; Sadikovic B; Buckley MF; O'Donnell-Luria A; Roscioli T
    Genet Med; 2024 May; 26(5):101076. PubMed ID: 38258669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
    Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
    Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Clinical Utility of Clinical Exome Sequencing in Children With Moderate and Severe Global Developmental Delay / Intellectual Disability.
    Stojanovic JR; Miletic A; Peterlin B; Maver A; Mijovic M; Borlja N; Dimitrijevic B; Soldatovic I; Cuturilo G
    J Child Neurol; 2020 Feb; 35(2):116-131. PubMed ID: 31623504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of partial exome sequencing in developmental disorders.
    Gieldon L; Mackenroth L; Kahlert AK; Lemke JR; Porrmann J; Schallner J; von der Hagen M; Markus S; Weidensee S; Novotna B; Soerensen C; Klink B; Wagner J; Tzschach A; Jahn A; Kuhlee F; Hackmann K; Schrock E; Di Donato N; Rump A
    PLoS One; 2018; 13(8):e0201041. PubMed ID: 30091983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
    Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
    Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).
    Manickam K; McClain MR; Demmer LA; Biswas S; Kearney HM; Malinowski J; Massingham LJ; Miller D; Yu TW; Hisama FM;
    Genet Med; 2021 Nov; 23(11):2029-2037. PubMed ID: 34211152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield of clinical exome sequencing in adulthood in medical genetics clinics.
    Mainali A; Athey T; Bahl S; Hung C; Caluseriu O; Chan A; Eaton A; Ghai SJ; Kannu P; MacPherson M; Niederhoffer KY; Siriwardena K; Mercimek-Andrews S
    Am J Med Genet A; 2023 Feb; 191(2):510-517. PubMed ID: 36401557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
    Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
    Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of clinical exome sequencing in the diagnostic procedure of patients with intellectual disability in clinical practice.
    Ballesta-Martínez MJ; Pérez-Fernández V; López-González V; Sánchez-Soler MJ; Serrano-Antón AT; Rodríguez-Peña LI; Barreda-Sánchez M; Armengol-Dulcet L; Guillén-Navarro E
    Orphanet J Rare Dis; 2023 Jul; 18(1):201. PubMed ID: 37480025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis.
    Nambot S; Thevenon J; Kuentz P; Duffourd Y; Tisserant E; Bruel AL; Mosca-Boidron AL; Masurel-Paulet A; Lehalle D; Jean-Marçais N; Lefebvre M; Vabres P; El Chehadeh-Djebbar S; Philippe C; Tran Mau-Them F; St-Onge J; Jouan T; Chevarin M; Poé C; Carmignac V; Vitobello A; Callier P; Rivière JB; Faivre L; Thauvin-Robinet C;
    Genet Med; 2018 Jun; 20(6):645-654. PubMed ID: 29095811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories.
    Stefka J; Streff H; Liu P; Towne M; Smith HS
    Genet Med; 2023 May; 25(5):100818. PubMed ID: 36852743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach.
    Krenn M; Tomschik M; Rath J; Cetin H; Grisold A; Zulehner G; Milenkovic I; Stogmann E; Zimprich A; Strom TM; Meitinger T; Wagner M; Zimprich F
    Eur J Neurol; 2020 Jan; 27(1):51-61. PubMed ID: 31407473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of exome sequencing and extended bioinformatic analyses in adolescents and adults with a broad range of neurological phenotypes: an Australian perspective.
    Eratne D; Schneider A; Lynch E; Martyn M; Velakoulis D; Fahey M; Kwan P; Leventer R; Rafehi H; Chong B; Stark Z; Lunke S; Phelan DG; O'Keefe M; Siemering K; West K; Sexton A; Jarmolowicz A; Taylor JA; Schultz J; Purvis R; Uebergang E; Chalinor H; Creighton B; Gelfand N; Saks T; Prawer Y; Smagarinsky Y; Pan T; Goranitis I; Ademi Z; Gaff C; Huq A; Walsh M; James PA; Krzesinski EI; Wallis M; Stutterd CA; Bahlo M; Delatycki MB; Berkovic SF
    J Neurol Sci; 2021 Jan; 420():117260. PubMed ID: 33310205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing.
    Hiraide T; Yamoto K; Masunaga Y; Asahina M; Endoh Y; Ohkubo Y; Matsubayashi T; Tsurui S; Yamada H; Yanagi K; Nakashima M; Hirano K; Sugimura H; Fukuda T; Ogata T; Saitsu H
    Clin Genet; 2021 Jul; 100(1):40-50. PubMed ID: 33644862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Utility of Clinical Exome Sequencing in Diagnosis of Rare Idiopathic Neurodevelopmental Disorders in Indian Population.
    Sheth H; Pancholi D; Bhavsar R; Mannan AU; Ganapathy A; Chowdhury M; Shah S; Solanki D; Sheth F; Sheth J
    Neurol India; 2021; 69(6):1729-1736. PubMed ID: 34979677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.